Pluri Inc. (Pluristem Therapeutics Inc.) 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on March 19, 2013, by Pluristem Therapeutics Inc., a Nevada corporation headquartered in Haifa, Israel. The report covers an event that occurred on March 17, 2013.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a corporate governance event and does not contain financial statements.
Material Changes
Effective March 17, 2013, Yaky Yanay was appointed as Executive Vice President of the registrant. He retains his existing positions as Chief Financial Officer and Secretary.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investors to Verify
- Confirmation of Yaky Yanay's expanded role as Executive Vice President alongside his CFO and Secretary duties.
- Review of the company's latest 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.
- Verification of any potential impact of this leadership change on the company's strategic direction.